SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
07-Sep-21 7:17 PM View: | Prelude Therapeutics Inc (PRLD) | 02-Sep-21 | Option Exercise | 17,000 | $12.85 | $218,450.00 | 453% 3.75K to 20.75K | |
07-Sep-21 7:17 PM View: | Prelude Therapeutics Inc (PRLD) | 02-Sep-21 | Market Option Sale (Planned) | 17,000 | $41.68 | $708,493.00 | (82%) 20.75K to 3.75K | |
30-Apr-21 6:24 PM View: | Prelude Therapeutics Inc (PRLD) | 29-Apr-21 | Option Exercise | 3,295 | $1.89 | $6,227.55 | 88% 3.75K to 7.04K | |
30-Apr-21 6:24 PM View: | Prelude Therapeutics Inc (PRLD) | 29-Apr-21 | Market Option Sale (Planned) | 3,295 | $40.29 | $132,765.00 | (47%) 7.04K to 3.75K | |
15-Apr-21 7:12 PM View: | Prelude Therapeutics Inc (PRLD) | 08-Apr-21 | Grant | 200 | $1.89 | $378.00 | 5% 3.75K to 3.95K | |
15-Apr-21 7:12 PM View: | Prelude Therapeutics Inc (PRLD) | 08-Apr-21 | Market Sale (Planned) | 200 | $40.00 | $8,000.00 | (5%) 3.95K to 3.75K | |
09-Apr-21 5:53 PM View: | Prelude Therapeutics Inc (PRLD) | 07-Apr-21 | Grant | 828 | $1.89 | $1,564.92 | 22% 3.75K to 4.58K | |
09-Apr-21 5:53 PM View: | Prelude Therapeutics Inc (PRLD) | 07-Apr-21 | Market Sale (Planned) | 828 | $40.08 | $33,188.40 | (18%) 4.58K to 3.75K | |
29-Sep-20 8:07 PM View: | Prelude Therapeutics Inc (PRLD) | 29-Sep-20 | Purchase | 3,750 | $19.00 | $71,250.00 | 100% 0 to 3.75K |